HOME >> MEDICINE >> NEWS
Statins show early promise for treating multiple sclerosis

Results of a preliminary study in this week's issue of THE LANCET suggest that statins (cholesterol-lowering drugs) could have potential in the treatment of multiple sclerosis (MS).

Drug treatments for MS are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS.

Inderjit Singh from the Medical University of South Carolina, USA, and colleagues report how 30 people with MS given 80 mg simvastatin daily for 6 months had a 44% reduction in the proportion of brain lesions after three months of treatment compared with lesions identified before treatment initiation.

Dr Singh comments: "These findings suggest that an 80 mg daily dose of oral simvastatin over a 6 month period could inhibit the inflammatory components of multiple sclerosis that lead to neurological disabilityOur results, combined with the published work on the immunological effects of statins lend support to the case for randomised controlled clinical trials to establish the safety and efficacy of statins in the treatment of relapsing-remitting multiple sclerosis".

In an accompanying Commentary (p 1570), Chris Polman from VU Medical Centre, Amsterdam, Netherlands, concludes: "[this] study is a big step forward because it is the first to provide some evidence of an effect with a statin in multiple sclerosis-but it is only an initial step. Additional data are required to more precisely determine the clinical effects of statins, to explore the optimum dose, the therapeutic window, and the differential potency of statins, and to evaluate whether combination therapy might be more effective than monotherapy. Physicians, scientists, drug companies, and regulatory agencies should now work together to design and do randomised studies that have adequate power to address these and other important issues. It is the joint responsibility of all involved to ensure that some
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
13-May-2004


Page: 1 2

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins and aspirin may protect against severe vision loss in elderly
3. Statins could reduce stroke risk by a third
4. Statins may inhibit calcium growth on aortic valve in the elderly
5. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
6. New marker for early diagnosis of kidney failure identified
7. English-speaking Hispanic youth more likely to have sex early
8. Inpatient smoking cessation counseling is associated with early differences in mortality
9. Study finds no reason for expectant mothers to shy away from early epidurals
10. No increase in C-sections when epidural analgesia given early in labor
11. Radiologists offer non-surgical treatment for early-stage liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/28/2020)... ... August 28, 2020 , ... The 15 scholarships being offered ... & Wellness mobile app and web-portal. NCPCV received a 2020 grant from Motorola ... each year to organizations, such as Destination Imagination, which support and advance public ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection (IVP ... Florida school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is ... Classical Academy plans to fully reopen equipped with the filtration system on September 8th. ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... international observations that strongly suggest that obese individuals are at an increased risk ... are any more likely to catch COVID-19; however, because the same organ systems ...
(Date:8/27/2020)... ... August 27, 2020 , ... The team at Sikara ... and wellness retreat. The practice is centered on results and providing the ultimate ... , Designed to be a sanctuary for total body renewal and aesthetic revitalization, ...
(Date:8/26/2020)... ... 26, 2020 , ... Smile Brands Inc. CEO, Steven C. ... leading a session entitled, “A CEO Guide for Delivering and Measuring Inclusion Success”. ... bring together the world’s leading diversity and inclusion executives, HR consultants, and D&I ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... FALLS CHURCH, Va. (PRWEB) , ... September 03, 2020 , ... ... a Statistician, An FDAnews Webinar, Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, ... were also an expert statistician? , While one can’t become one in 90 ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ( http://www.aptt3x.com ... The Counter (OTC) products, was today provided results of an independent laboratory ...
(Date:9/1/2020)... ROCHESTER, N.Y. (PRWEB) , ... September 01, 2020 ... ... board-certified dermatologist, and Director of Cosmetics and Laser Surgery at the University of ... and Dermatologic Surgery fellowship at SkinCare Physicians in Boston, with clinical faculty from ...
Breaking Medicine Technology:
Cached News: